Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

WuXi PharmaTech (Cayman) Inc. (WX)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-14Dec-31-13Dec-31-12Dec-31-11Dec-31-10Dec-31-09Dec-31-08
   20-F20-F20-F20-F20-F20-F20-F
Net income  112.2114.686.681.090.852.9-64.2
Depreciation and amortization  46.444.741.734.029.224.031.0
Stock-based compensation  21.615.513.310.29.29.313.0
Deferred taxes  -1.44.83.22.30.1-3.2-23.4
Change in working capital   [+]-41.3-0.5-28.5-31.1-8.4-15.2-14.5
Other operating activities  -134.0-173.9-116.0-94.5-97.8-70.7118.7
Cash from operations  3.45.20.31.923.2-3.060.7
   
Capital expenditures   [+]-98.1-57.5-66.9-79.3-48.9-55.0-63.3
Purchases of intangible assets  -10.0-2.7-1.0-0.6-0.5-0.3-0.7
Acquisitions  -23.9-0.8 -12.6 -13.5-142.3
Purchases of short-term investments, net  98.7-119.3-46.3-84.6-14.8-7.3-14.4
Other cash from investing  109.2156.6199.0150.050.267.45.3
Cash from investing  80.4-5.384.9-27.0-14.0-8.7-215.2
   
Repurchase of common stock, net  -98.9-1.2-30.0    
Option exercises  2.24.91.41.62.41.41.0
Other cash from financing  34.59.9-54.223.3-5.312.8-4.5
Cash from financing  -66.73.8-85.621.6-7.611.4-5.5
   
Free cash flow  -94.7-52.2-66.6-77.4-25.7-58.0-2.6
        Per share (diluted)  ($0.16)($0.09)($0.11)($0.13)($0.04)($0.10)($0.01)
   
Cash paid for interest  -1.9-2.0-1.6-0.6-0.8-1.7-1.1

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy